Sex differences in risk factors for clinical diabetes mellitus in a general population: A 12-year follow-up of the Finnmark Study

American Journal of Epidemiology

Volumn 147, Issue 1, 1998, Pages 49-58

  Njølstad, Inger ^a   Arnesen, E ^a   Lund Larsen, P G ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b National Health Screening Service   (Norway)

Author keywords

Diabetes mellitus, non insulin dependent; Prospective studies; Risk factors; Sex

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 0031973516     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009366     Document Type: Article

References (58)

1. Dowse GK, Zimmet PZ. The prevalence and incidence of non-insulin dependent diabetes mellitus. In: Alberti KGMM, Mazze RS, eds. Frontiers in diabetes research: current trends in non-insulin-dependent diabetes mellitus. Amsterdam: Elsevier Science Publishers BV, 1989:37-59.
2. McCarthy M, Hitman GA. The genetic aspects of non-insulin-dependent diabetes mellitus. In: Leslie RDG, ed. Causes of diabetes. Genetic and environmental factors. Chicester: John Wiley & Sons, Ltd, 1993:157-83.
3. Westlund K. Incidence of diabetes mellitus in Oslo, Norway, 1925 to 1954. Report no. 11 of the Life Insurance Companies' Institute for Medical Statistics at the Oslo City hospitals. Br J Prev Soc Med 1966;20:105-16.
4. O'Dea K. Diabetes in Australian Aborigines: impact of the western diet and life style. J Intern Med 1992;232:103-17.
5. Collins VR, Dowse GK, Toelupe PM, et al. Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 1994;17:288-96.
6. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: chicken, egg, or neither? Diabetologia 1984;26:99-102.
7. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
8. Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996;124:110-16.
9. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:123-31.
10. Barren-Connor EL, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-31.
11. Laakso M, Rönnemaa T, Lehto S, et al. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 1995;38:487-93.
12. Walden CE, Knopp RH, Wahl PW, et al. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984;311:953-9.
13. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years. The Framingham Study. Am J Epidemiol 1981;114: 697-704.
14. Lundgren H, Bengtsson C, Blohme G, et al. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes 1989;13:413-23.
15. Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 1991;53:1534S-51S.
16. McPhillips JB, Barrett-Connor E, Wingard DL, Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990;131: 443-53.
17. Nelson RG, Sievers ML, Knowler WC, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990;81:987-95.
18. National Health Screening Service, Health Services of Finnmark, Oppland, and Sogn og Fjordane counties, Ullevål Hospital, Central Laboratory, Oslo. The Cardiovascular Disease Study in Norwegian Counties: results from second screening. Oslo: National Health Screening Service, 1988.
19. Thelle DS, Førde OH, Arnesen E. Distribution of high-density lipoprotein cholesterol according to age, sex, end ethnic origin: cardiovascular study in Finnmark 1977. J Epidemiol Community Health 1982;36:243-7.
20. The Oslo Study. The quantitative determination of cholesterol, triglycerides, and glucose in blood serum. Laboratory protocol no. 2. Oslo: Ullevaal Hospital, Central Laboratory, 1975.
21. World Health Organization. Diabetes mellitus: report of a WHO Study Group. Geneva: World Health Organization, 1985. (Technical report no. 727).
22. Manson JA, Rimm EB, Stampfer MJ, et al. A prospective study of exercise and incidence of diabetes among U.S. male physicians. JAMA 1992;268:63-7.
23. Westlund K, Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol A follow-up of 3,751 men aged 40-49. Scand J Clin Lab Invest Suppl 1972;30:1-24.
24. Koivisto VA, Yki-Jarvinen H, DeFronzo RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1986;1: 445-81.
25. Ohlson LO, Larsson B, Björntorp P, et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988;31:798-805.
26. Skarfors ET, Selinus KI, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 1991;303:755-60.
27. Perry IJ, Wannamethee SG, Walker MK, et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995;310:560-4.
28. Feskens EJM, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen Study. Am J Epidemiol 1989;130:1101-8.
29. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132:501-13.
30. Krotkiewski M, Björntorp P, Sjöström L, et al. Impact of obesity on metabolism in men and women, Importance of regional adipose tissue distribution. J Clin Invest 1983;72: 1150-62.
31. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826-34.
32. Evans DJ, Huffman RG, Kalkhof RK, et al. Relationships of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984;33:68-75.
33. Evans DJ, Hoffmann RG, Kalkhoff RK, et al. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983;57:304-10.
34. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
35. Kaplan N. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
36. Wilson PWF, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med 1986;80(suppl 5A):3-9.
37. Bengtsson C, Blohmé G, Lapidus L, et al. Do antihypertensive drugs precipitate diabetes? Br Med J 1984;289:1495-7.
38. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334: 374-81.
39. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993;83:211-14.
40. Johnston FE. Somatic growth of the infant and preschool child. In: Falkner F, Tanner JM, eds. Human growth. Vol 2. New York: Plenum Press, 1986:3-23.
41. Williams DRR, Wareham NJ, Brown DC, et al. Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 1995;12:30-5.
42. Barker DJP, Hales CN, Fall CHD, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and hyperlipidemia (Syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-7.
43. Sayeed MA, Banu A, Khan AR, et al. Prevalence of diabetes and hypertension in a rural population of Bangladesh. Diabetes Care 1995;18:555-8.
44. Phipps K, Barker DJP, Hales CN, et al. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993;36:225-8.
45. Phillips DIW, Barker DJP, Hales CN, et al. Thinness at birth and insulin resistance in adult life. Diabetologia 1994;37: 150-4.
46. Midthjell K, Bjørndal A, Holmen J, et al. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study. Scand J Prim Health Care 1995;13:229-35.
47. Harris MI. Prevalence of non-insulin-dependent diabetes and impaired glucose tolerance. In: National Diabetes Data Group, ed. Diabetes in America: diabetes data compiled 1984. Bethesda: National Institutes of Health, 1985. (DHHS publication no. (PHS) 85-1468).
48. Joner G. Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. Diabetologia 1989;32:79-83.
49. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-32.
50. Statistics Norway. Causes of death 1993. Oslo-Kongsvinger: Statistics Norway, 1995.
51. Westlund K, Søgaard AJ. Helse, livsstil og levekår i Finnmark. Resultater fra Hjerte-karundersøkelsen i 1987-88. Finnmark III. (In Norwegian). Tromsø: University of Tromsø, 1993. (ISM skriftserie nr. 28).
52. Bonithon-Kopp C, Scarabin PY, Darne B, et al. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol 1990;19:42-8.
53. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321:641-6.
54. Haffner SM, Valdez RA, Morales PA, et al. Decreased sex hormone-binding globulin predicts non-insulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:55-60.
55. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women, The Postmenopausal Estrogen/ Progestin Interventions (PEPI) Trial. JAMA 1995;273: 199-208.
56. Barrett-Connor E, Brown WV, Turner J, et al. Heart disease risk factors and hormone use in postmenopausal women. JAMA 1979;241:2167-9.
57. Manson JE, Rimm EB, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol 1992;2:665-73.
58. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996;93:450-6.